Metastasis suppressor NME1 promotes non-homologous end joining of DNA double-strand breaks

DNA Repair (Amst). 2019 May:77:27-35. doi: 10.1016/j.dnarep.2019.03.003. Epub 2019 Mar 4.

Abstract

NME1 (also known as NM23-H1) was the first identified tumor metastasis suppressor, which has been reported to link with genomic stability maintenance and cancer. However its underlying mechanisms are still not fully understood. Here we find that NME1 is required for non-homologous end joining (NHEJ) of DNA double-strand breaks (DSBs). Mechanistically, NME1 re-localizes to DNA damage sites in a Ku-XRCC4-dependent manner, and regulates downstream LIG4 recruitment and end joining efficiency. Furthermore, we show that the 3'-5' exonuclease activity of NME1 is critical for its function in NHEJ. Taken together, our findings identify NME1 as a novel NHEJ factor, and reveal how this metastasis suppressor promotes genome stability.

Keywords: 3′-5′ exonuclease; DNA double-strand breaks; Genomic stability; NHEJ; NME1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • DNA Breaks, Double-Stranded*
  • DNA End-Joining Repair*
  • DNA Ligase ATP / metabolism
  • DNA-Binding Proteins / metabolism
  • Humans
  • NM23 Nucleoside Diphosphate Kinases / metabolism*
  • Neoplasm Metastasis

Substances

  • DNA-Binding Proteins
  • LIG4 protein, human
  • NM23 Nucleoside Diphosphate Kinases
  • XRCC4 protein, human
  • DNA Ligase ATP